Minister Anil Vij says Bharat Biotech Starts Human Trial of Anti-COVID Vaccine at PGI Rohtak

The human trial of Bharat Biotech's anti-COVID-19 vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij wrote on Twitter.

"Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today," Vij, who is also the Home and Science & Technology minister said.

"Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects," Vij further said in his



tweet.

Bharat Biotech got the nation's medication controller's endorsement to begin clinical preliminaries of its enemy of Corona immunization Covaxin as of late. 

There are more than seven enemy of crown antibodies at different phases of advancement in the nation with two of them having gotten the medication controller's thumbs up to begin the human clinical preliminaries of their immunizations.

Earlier this month, Zydus had said it has received approval from authorities to start human trials for its anti-COVID-19 vaccine.